cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Dermtech Inc
26 own
8 watching
Current Price
$5.4
$-0.09
(-1.64%)
logo-dmtk
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
163.15M
52-Week High
52-Week High
16.33
52-Week Low
52-Week Low
1.55
Average Volume
Average Volume
0.74M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization163.15M
icon52-Week High16.33
icon52-Week Low1.55
iconAverage Volume0.74M
iconDividend Yield--
iconP/E Ratio--
What does the Dermtech Inc do?
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Read More
How much money does Dermtech Inc make?
News & Events about Dermtech Inc.
Business Wire
5days ago
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to four new employees of restricted stock units representing the contingent right to receive up to an aggregate of 44,669 shares of...
Business Wire
9days ago
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced favorable coverage policies from two commercial payers comprising a Blues plan in Hawaii and a physician-founded, member-focused and...
Business Wire
22days ago
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the Defense Health Agencys Lab Joint Working Group has recommended the Companys foundational assay included in the DermTech Melanoma Test...
Ticker Report
9 months ago
Landscape Capital Management L.L.C. raised its holdings in shares of DermTech, Inc. (NASDAQ:DMTK Get Rating) by 187.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 176,226 shares of the companys stock after purchasing an additional 115,023 shares during the quarter...
Business Wire
11 months ago
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that SKIN: The Journal of Cutaneous Medicine has published its original research study, with Daniel M. Siegel, MD, MS as the lead author. A...
Frequently Asked Questions
Frequently Asked Questions
What is Dermtech Inc share price today?
plus_minus_icon
Can Indians buy Dermtech Inc shares?
plus_minus_icon
How can I buy Dermtech Inc shares from India?
plus_minus_icon
Can Fractional shares of Dermtech Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Dermtech Inc stocks?
plus_minus_icon
What is today’s traded volume of Dermtech Inc?
plus_minus_icon
What is today’s market capitalisation of Dermtech Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Dermtech Inc?
plus_minus_icon
What percentage is Dermtech Inc down from its 52-Week High?
plus_minus_icon
What percentage is Dermtech Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.4
$-0.09
(-1.64%)
logo-dmtk
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$46.42
$0.17 (0.37 %)
APOLLO MEDICAL HOLDINGS INC
APOLLO MEDICAL HOLDINGS INC
$35.64
$1.42 (4.15 %)
agilon health, Inc.
agilon health, Inc.
$21.76
$1.15 (5.58 %)
OptimizeRx Corporation
OptimizeRx Corporation
$17.95
$0.55 (3.16 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$46.42
$0.17 (0.37 %)
APOLLO MEDICAL HOLDINGS INC
APOLLO MEDICAL HOLDINGS INC
$35.64
$1.42 (4.15 %)
agilon health, Inc.
agilon health, Inc.
$21.76
$1.15 (5.58 %)
OptimizeRx Corporation
OptimizeRx Corporation
$17.95
$0.55 (3.16 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00